Literature DB >> 944152

Gastrins in tissue. Concentration and component pattern in gastric, duodenal, and jejunal mucosa of normal human subjects and patients with duodenal ulcer.

J Malstrom, F Stadil, J F Rehfeld.   

Abstract

The total concentration of gastrin and distribution of gastrin components were examined in mucosal biopsies from corpus, antrum, duodenum, and jejunum from normal subjects and patients with duodenal ulcer. The concentration was highest in the antrum, being 12.1+/-1.9 nmol per g of mucosa (mean +/-SEM) for normal subjects, and 9.0 +/-1.6 nmol per g of mucosa for duodenal ulcer patients (P eaual to 0.03). A steep gradient was found distally: in the proximal duodenum the concentration was 0.1; in the distal duodenum, 0.02 to 0.01; and in the proximal jejunum, less than 0.01 of the antral concentration. In corpus of the stomach, the concentrations were similar to those found in the jejunum. Gel filtrations showed that most gastrin immunoreactivity was eluted in positions corresponding to serum component II (gastrin-34-like) and III (gastrin-17-like), but immunoreactivity corresponding to all the components present in serum was found. No interference from cholecystokinin was observed in duodenal biopsies. In corpus, antrum, and jejunum component III was the predominant form, whereas component II made up half of immunoreactive gastrin in the duodenum. No major differences were observed between normal subjects and duodenal ulcer patients. There was no simple relationship between acid secretion and mucosal gastrin concentration, but ulcer patients with the highest acid secretion had the lowest antral content and the highest duodenal content.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 944152

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  19 in total

1.  Heptadecapeptide gastrin in the vagal nerve.

Authors:  K Uvnäs-Wallensten; J F Rehfeld; L I Larsson; B Uvnäs
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

2.  Identification of progastrin in gastrinomas, antrum, and duodenum by a novel radioimmunoassay.

Authors:  S Pauwels; H Desmond; R Dimaline; G J Dockray
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

3.  Immunocytochemical evidence for differential distribution of gastrin forms using region-specific monoclonal antibodies.

Authors:  T Azuma; D Abrahm; J H Walsh
Journal:  Gastroenterol Jpn       Date:  1986-08

4.  Comparison of intraduodenal and intravenous administration of amino acids on gastric secretion in healthy subjects and patients with duodenal ulcer.

Authors:  S J Konturek; N Kwiecień; W Obtułowicz; E Mikoś; E Sito; J Oleksy
Journal:  Gut       Date:  1978-10       Impact factor: 23.059

5.  Metabolism of heptadecapeptide gastrin in humans studied by region-specific antisera.

Authors:  S Pauwels; G J Dockray; R Walker; S Marcus
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

6.  Duodenal gastrin concentration in upper gastrointestinal disorders.

Authors:  W S Hughes
Journal:  Dig Dis Sci       Date:  1986-11       Impact factor: 3.199

7.  Pathways of processing of the gastrin precursor in rat antral mucosa.

Authors:  A Varro; S Voronina; G J Dockray
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

8.  Gastric response to meat extract stimulation in patients with gastroduodenal ulcer and patients after vagotomy or antrectomy.

Authors:  M Tani; H Shimazu; T Takahashi; S Asakuma
Journal:  Jpn J Surg       Date:  1978-03

9.  Secretion and biosynthesis of COOH-terminal glycine extended progastrin (gastrin-G) in rat gastric antrum.

Authors:  T Azuma
Journal:  Gastroenterol Jpn       Date:  1987-04

10.  Origin of gastrin liberated by gastrin releasing peptide in man.

Authors:  L Lundell; G Lindstedt; L Olbe
Journal:  Gut       Date:  1987-09       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.